Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

NCT01916109 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Bladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Carboplatin
DRUG: Panitumumab
PROCEDURE: radical cystectomy

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]